Researchers uncover new operations of cancer suppressor

February 24, 2012, University of Dundee

(Medical Xpress) -- Scientists at the University of Dundee studying an important tumour suppressor, which is involved in at least a quarter of all cancers, have uncovered new ways in which it works.

The research team at the College of Life Sciences at Dundee have been studying the protein , which when 'turned off' or damaged drives the development of many cancers.

By studying cells, the Dundee team led by Dr Nick Leslie found that some damaged PTEN proteins can still operate in many of their normal ways but importantly lose the ability to stop cancer cells invading the .

Brain tumours are particularly deadly, having a very , because although they rarely spread outside the brain, by the time they are diagnosed, some cancer cells have usually moved away from the original tumour and infiltrated the surrounding brain tissue. Therefore, when a surgeon removes the initial tumour, it is often not long before a second tumour grows from the few cancer cells in the surrounding .

Dr Leslie's team set up experiments, using a 3D matrix similar to that found between cells in the brain, to investigate this process of how invade from a tumour mass into healthy tissue. Their work, published in the journal Science Signalling, describes how PTEN controls the way these brain tumour cells grow, change their shape, switch particular on and off and importantly how PTEN normally stops this invasion process.

"We know that PTEN has lots of effects on what cells do, but it has proved harder to be certain which of these effects are important in stopping cancer and therefore which ones we should develop drugs to target," said Dr Leslie.

"It is really important we understand the factors driving these cancers, which affect thousands of people every year in the UK."

Dr Leslie said a lot was already known about one way in which PTEN can stop cells growing and dividing, but there have been several hints in the past that there are other undiscovered ways in which PTEN may stop cancers developing.

"In our new work, we've used two similarly damaged versions of PTEN, one of which was found in a tumour, that we show can still do the best recognised things that PTEN does, just as well as normal PTEN . However, these damaged proteins have completely lost the ability to stop brain tumours cells invading through a 3D matrix. This implies that in some, and perhaps many, tumours it is not the best known things that PTEN does that explain why it gets damaged, but instead it must be these new ways that PTEN can work that we know much less about."

The work also identified a 'gene signature' (showing which genes are turned on and off in particular cells) that is controlled by PTEN, which links to its control of invasion, but not its best recognised ways of working.

"Interestingly this gene signature also seemed to be recognisable in almost all of a large set of human brain tumour samples that lack or have damaged PTEN, providing more evidence that this new way in which PTEN works may be important in brain tumour development," said Dr Leslie.

"The key goals of future work in this area need to include understanding much more about these new ways in which PTEN can work and whether they show us new ways to develop drugs to treat brain and other tumours."

The work of Dr Leslie and the Dundee team has been supported by funding from the Medical Research Council and the Association for International Cancer Research.

Explore further: New research sheds light on gene destruction linked to aggressive prostate cancer

Related Stories

New research sheds light on gene destruction linked to aggressive prostate cancer

January 26, 2012
Researchers at Queen's University in Kingston, Canada have identified a possible cause for the loss of a tumour suppressor gene (known as PTEN) that can lead to the development of more aggressive forms of prostate cancer.

Scientists find protein's bad guy role in prostate cancer

May 10, 2011
It's a disease affecting those closest to us – our fathers, brothers and sons.

Targeting PTEN may prevent skin cancer

July 26, 2011
Scientists believe they have identified a role for PTEN, a known tumor suppressor, in removing DNA damage derived from UVB radiation, a known risk factor for non-melanoma skin cancer, according to a study published in Cancer ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.